Guardant Health, Inc. - Common Stock (NQ:GH)

182.93 +5.13 (+2.89%)

Delayed Quote Updated: 1:16 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Guardant Health, Inc. - Common Stock

< Previous 1 2

...

5 6 7 8 9 10 11 12 13

...

23 24 Next >

10 Health Care Stocks With Whale Alerts In Today's Session ↗

May 09, 2025

Via Benzinga

Guardant Health to Participate in Upcoming Investor Conferences

May 08, 2025

From Guardant Health, Inc.

Via Business Wire

TIME Names Guardant Health Co-CEOs to 2025 TIME100 Health List of the 100 Most Influential People in Global Health This Year

May 08, 2025

From Guardant Health, Inc.

Via Business Wire

Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

May 07, 2025

From Guardant Health, Inc.

Via Business Wire

Earnings Scheduled For April 30, 2025 ↗

April 30, 2025

Via Benzinga

Netflix, CNA Financial And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

May 05, 2025

Via Benzinga

Cathie Wood Pours $9.8 Million In Robinhood Despite Crypto Revenue Slump, Keeps Dumping Palantir Ahead Of Earnings ↗

May 01, 2025

Cathie Wood's Ark Invest Makes Bold $9.8M Robinhood Bet While Dumping Palantir Ahead of Earnings.

Via Benzinga

Guardant Health’s (NASDAQ:GH) Q1: Strong Sales, Stock Soars

April 30, 2025

Diagnostics company Guardant Health (NASDAQ:GH) reported Q1 CY2025 results topping the market’s revenue expectations, with sales up 20.8% year on year to $203.5 million. The company’s full-year revenue...

Via StockStory

Guardant Health Reports First Quarter 2025 Financial Results and Increases 2025 Revenue Guidance

April 30, 2025

From Guardant Health, Inc.

Via Business Wire

Guardant Health Presents Data Demonstrating Strong Performance of Shield Multi-Cancer Detection Test Across 10 Tumor Types

April 29, 2025

From Guardant Health, Inc.

Via Business Wire

Guardant Health (GH) Q1 Earnings Report Preview: What To Look For

April 29, 2025

Diagnostics company Guardant Health (NASDAQ:GH) will be reporting earnings tomorrow after market hours. Here’s what you need to know.

Via StockStory

Topics World Trade

Pfizer Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts ↗

April 29, 2025

Via Benzinga

CORRECTING and REPLACING Guardant Health Launches Guardant360 Tissue, First Tissue Molecular Profiling Test with Comprehensive Multiomic Analysis to Provide a More Complete View of Cancer

April 28, 2025

From Guardant Health, Inc.

Via Business Wire

Guardant Health, Pfizer Collaborate To Develop New Cancer Therapies Using Liquid Biopsy Platform ↗

April 24, 2025

Guardant Health partners with Pfizer to support oncology drug development using smart liquid biopsy tech and expand testing access in China.

Via Benzinga

Guardant Health Announces Strategic Collaboration With Pfizer to Support Development and Commercialization of New Cancer Therapies Using Guardant Infinity Smart Liquid Biopsy Platform

April 24, 2025

From Guardant Health, Inc.

Via Business Wire

Guardant Health to Present Data Highlighting Advances in Multi-Cancer Detection and Liquid and Tissue Molecular Profiling at AACR

April 22, 2025

From Guardant Health, Inc.

Via Business Wire

RXO, The Ensign Group, LifeStance Health Group, Surgery Partners, and Guardant Health Stocks Trade Down, What You Need To Know

April 21, 2025

A number of stocks fell in the afternoon session after President Trump criticized the Federal Reserve's approach to interest rate cuts, warning that the pace was slow and could hinder economic growth....

Via StockStory

Topics Economy Government World Trade

3 Reasons to Sell GH and 1 Stock to Buy Instead

April 21, 2025

What a time it’s been for Guardant Health. In the past six months alone, the company’s stock price has increased by a massive 112%, reaching $44.11 per share. This run-up might have investors...

Via StockStory

Topics Bankruptcy

3 of Wall Street’s Favorite Stocks Facing Headwinds

April 18, 2025

The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because...

Via StockStory

The Blood Test Revolution: It's A New Day In Cancer. Guardant, Natera And Exact Are Here For It. ↗

April 17, 2025

A revolution in oncology could help cancer survivors in the U.S. and bolster Guardant Health, Natera and Exact Sciences.

Via Investor's Business Daily

Guardant Health to Report First Quarter 2025 Financial Results on April 30, 2025

April 10, 2025

From Guardant Health, Inc.

Via Business Wire

Reflecting On Testing & Diagnostics Services Stocks’ Q4 Earnings: Guardant Health (NASDAQ:GH)

April 08, 2025

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how testing & diagnostics services stocks fared in Q4, starting...

Via StockStory

Testing & Diagnostics Services Stocks Q4 Recap: Benchmarking NeoGenomics (NASDAQ:NEO)

April 03, 2025

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the testing & diagnostics services stocks, including NeoGenomics (NASDAQ:NEO) and its peers.

Via StockStory

3 Small-Cap Stocks in the Doghouse

April 01, 2025

Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside...

Via StockStory

4 Healthcare Stocks With Massive Gains—and More to Come

March 29, 2025

Healthcare is the top industry of 2025 so far. These healthcare companies have seen 30% increases in share prices since the beginning of the year.

Via MarketBeat

Topics Artificial Intelligence Economy World Trade

The Future of Healthcare: 10 Predictions For The Next Decade

March 27, 2025

The healthcare industry stands on the brink of a transformative decade, driven by rapid advancements in technology, shifting demographics, and evolving patient expectations. Over the next ten years, we...

Via MarketMinute

Topics Artificial Intelligence

A Look Back at Testing & Diagnostics Services Stocks’ Q4 Earnings: Labcorp (NYSE:LH) Vs The Rest Of The Pack

March 27, 2025

Looking back on testing & diagnostics services stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Labcorp (NYSE:LH) and its peers.

Via StockStory

Q4 Testing & Diagnostics Services Earnings: RadNet (NASDAQ:RDNT) Impresses

March 26, 2025

Via StockStory

Guardant Health’s Shield Blood Test Now Covered for VA Community Care Beneficiaries

March 25, 2025

From Guardant Health, Inc.

Via Business Wire

1 Healthcare Stock on Our Watchlist and 2 to Turn Down

March 20, 2025

Personal health and wellness is one of the many secular tailwinds for healthcare companies. But financial performance has lagged recently as players offloaded surplus COVID inventories in 2023 and...

Via StockStory

Topics Stocks

< Previous 1 2

...

5 6 7 8 9 10 11 12 13

...

23 24 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.